Skip to content
Grants Management System
CIRM Hub Portal
Contact
Search
Search
Close this search box.
About
Our Mission
Our Impact
Our Governing Board
Our Team
Annual Reports
For Researchers
Funding Opportunities
Information for Applicants
Researcher Resources
Our Review Process
Our Programs
Grants Dashboard
Research and Development
Education and Training
Patient Access
Patient Resources
Stem Cell and Genetic Research
From Bench to Bedside
Community Outreach
CIRM Clinical Trials
Community Stories
News and Events
Press Releases
Public Meetings
Blog
Webinars and Workshops
Menu
About
Our Mission
Our Impact
Our Governing Board
Our Team
Annual Reports
For Researchers
Funding Opportunities
Information for Applicants
Researcher Resources
Our Review Process
Our Programs
Grants Dashboard
Research and Development
Education and Training
Patient Access
Patient Resources
Stem Cell and Genetic Research
From Bench to Bedside
Community Outreach
CIRM Clinical Trials
Community Stories
News and Events
Press Releases
Public Meetings
Blog
Webinars and Workshops
Mr. Samuel V. Alworth MS, MBA
Return to Grants
Institution Name:
AcuraStem Incorporated
Total Awards:
2
Award Value:
$4,012,325
Awards as PI
Program Type
Institution
Grant Title
Award Value
Therapeutic Translational Research Projects
AcuraStem Incorporated
Development of AS-241, an UNC13A Targeting Antisense Oligonucleotide (ASO) Treatment for ALS, for IND-enabling Studies
$4,012,325
Late Stage Preclinical Projects
AcuraStem Incorporated
Manufacturing of AS-202, an Antisense oligonucleotides for a Phase 1/2 Clinical Trial for Amyotrophic Lateral Sclerosis
$0
Total:
$4,012,325.00